TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 MAIN
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Surgery
    DivisionSurgery-Transplant Division

    Collapse Overview 
    Collapse overview
    Dr. Gagan Sood's primary research focuses on clinical aspects of liver disease, viral hepatitis, portal hypertension and outcome based research in cirrhosis and liver transplantation. His area of main interest is non-alcoholic fatty liver disease (NAFLD/ NASH). He is particularly interested in studying spectrum of NAFLD in different ethnic groups, with focus on genetic and metabolic differences in Hispanic population. Dr. Sood is also interested in iron overload in patient with liver disease including patients with NAFLD. Studies are currently being conducted on non-HFE related genetic markers in patients with primary and secondary iron overload. He is also involved in clinical trials of new anti viral therapies in patients with hepatitis C.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Balakrishnan M, Seth A, Cortes-Santiago N, Jain S, Sood GK, El-Serag HB, Thrift AP. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393. PMID: 32757159.
      Citations: 2     Fields:    Translation:Humans
    2. Sharma N, Darr U, Darr A, Sood G. Stauffer Syndrome: A Comprehensive Review of the Icteric Variant of the Syndrome. Cureus. 2019 Oct 30; 11(10):e6032. PMID: 31824799.
      Citations: 4     
    3. Sharma N, Darr U, Darr A, Sood GK. Macro-aspartate Aminotransferase: Misleading Finding in a Patient with Non-alcoholic Fatty Liver Disease. Cureus. 2019 Jun 29; 11(6):e5042. PMID: 31497458.
      Citations: 2     
    4. Sawhney R, Dhingra S, Sood GK. Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave's Disease. Cureus. 2019 May 04; 11(5):e4598. PMID: 31281763.
      Citations: 2     
    5. Kourkoumpetis T, Sood G. Pathogenesis of Alcoholic Liver Disease: An Update. Clin Liver Dis. 2019 02; 23(1):71-80. PMID: 30454834.
      Citations: 14     Fields:    Translation:HumansCells
    6. Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47. PMID: 29291380.
      Citations: 11     Fields:    Translation:Humans
    7. Rana A, Witte ED, Halazun KJ, Sood GK, Mindikoglu AL, Sussman NL, Vierling JM, Kueht ML, Galvan NTN, Cotton RT, O'Mahony CA, Goss JA. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12). PMID: 29044759.
      Citations: 4     Fields:    Translation:Humans
    8. Schvartsman G, Perez K, Sood G, Katkhuda R, Tawbi H. Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma. Ann Intern Med. 2017 Sep 05; 167(5):361-362. PMID: 28761949.
      Citations: 11     Fields:    Translation:Humans
    9. Patil R, Sood GK. Non-alcoholic fatty liver disease and cardiovascular risk. World J Gastrointest Pathophysiol. 2017 May 15; 8(2):51-58. PMID: 28573067.
      Citations: 44     
    10. Lin M, Mittal S, Sahebjam F, Rana A, Sood GK. Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: A systematic review and meta-analysis. Clin Transplant. 2017 02; 31(2). PMID: 27862340.
      Citations: 8     Fields:    Translation:Humans
    11. Al-Azzawi H, Patel R, Sood G, Kapoor S. Plasmapheresis for Refractory Pruritus due to Drug-Induced Cholestasis. Case Rep Gastroenterol. 2016 Sep-Dec; 10(3):814-818. PMID: 28203129.
      Citations: 1     
    12. Tasleem S, Sood GK. Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy. J Clin Transl Hepatol. 2015 Jun 28; 3(2):134-9. PMID: 26357640.
      Citations: 13     
    13. Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014 Apr 21; 20(15):4115-27. PMID: 24764650.
      Citations: 180     Fields:    Translation:HumansCells
    14. Sagi SV, Mittal S, Kasturi KS, Sood GK. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010 May; 25(5):880-5. PMID: 20074149.
      Citations: 34     Fields:    Translation:Humans
    15. Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, Sood GK. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):192-9. PMID: 19879972.
      Citations: 72     Fields:    Translation:Humans
    16. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1396-402. PMID: 18986848.
      Citations: 141     Fields:    Translation:Humans
    17. Tarçin O, Gedik N, Karakoyun B, Tahan V, Sood G, Celikel C, Tözün N. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats. Dig Dis Sci. 2008 Jul; 53(7):1938-45. PMID: 17999185.
      Citations: 7     Fields:    Translation:Animals
    18. van Leeuwen DJ, Sood G, Ferrante D, Lazenby AJ, Sellers MJ. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity! Semin Liver Dis. 2002 Nov; 22(4):395-406. PMID: 12447711.
      Citations: 2     Fields:    Translation:Humans
    SOOD's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (94)
    Co-Authors (18)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors